TransMedics Group, Inc. (BIT:1TMDX)
108.40
+4.80 (4.63%)
At close: May 13, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
United States OCS Transplant | 421.88M |
Log In |
Log In |
Log In |
Log In |
United States OCS Transplant Growth | 90.60% |
Log In |
Log In |
Log In |
Log In |
All Other Countries OCS Transplant | 15.28M |
Log In |
Log In |
Log In |
Log In |
All Other Countries OCS Transplant Growth | -0.69% |
Log In |
Log In |
Log In |
Log In |
Total OCS Transplant | 437.16M |
Log In |
Log In |
Log In |
Log In |
Total OCS Transplant Growth | 84.66% |
Log In |
Log In |
Log In |
Log In |
United States Lung | 15.76M |
Log In |
Log In |
Log In |
Log In |
United States Lung Growth | 49.36% |
Log In |
Log In |
Log In |
Log In |
United States Heart | 96.66M |
Log In |
Log In |
Log In |
Log In |
United States Heart Growth | 63.61% |
Log In |
Log In |
Log In |
Log In |
United States Liver | 309.46M |
Log In |
Log In |
Log In |
Log In |
United States Liver Growth | 103.97% |
Log In |
Log In |
Log In |
Log In |
All Other Countries Lung | 1.93M |
Log In |
Log In |
Log In |
Log In |
All Other Countries Lung Growth | 51.42% |
Log In |
Log In |
Log In |
Log In |
All Other Countries Heart | 13.20M |
Log In |
Log In |
Log In |
Log In |
All Other Countries Heart Growth | -5.81% |
Log In |
Log In |
Log In |
Log In |
All Other Countries Liver | 158.00K |
Log In |
Log In |
Log In |
Log In |
All Other Countries Liver Growth | - |
Log In |
Log In |
Log In |
Log In |
Other Service | 4.38M |
Log In |
Log In |
Log In |
Log In |
Net Product | 273.87M |
Log In |
Log In |
Log In |
Log In |
Net Product Growth | 55.54% |
Log In |
Log In |
Log In |
Log In |
Service | 167.67M |
Log In |
Log In |
Log In |
Log In |
Service Growth | 155.78% |
Log In |
Log In |
Log In |
Log In |